The stock has demonstrated strong overall performance, with a 34.06% gain over the past three months and a 26.14% gain over six months, significantly outperforming the broader market. In the short term, the stock declined 6.45% over the past month, underperforming the S&P 500's -5.25% change, indicating recent relative weakness. The current price of $61.05 is near the upper end of its 52-week range of $33.60 to $67.00, representing approximately 91% of the range's high, suggesting the stock is trading at elevated levels.

Revenue in Q4 2025 was $7.39 billion, showing minimal year-over-year growth of 0.3% compared to Q4 2024. Profitability was solid with a net margin of 11.86% for the quarter, though this was down from 16.01% in the prior-year quarter, indicating some margin compression. The company maintains a healthy balance sheet with a debt-to-equity ratio of 0.38 and a current ratio of 1.36, reflecting manageable leverage and sufficient short-term liquidity. Operational efficiency is adequate, with a Return on Equity (ROE) of 13.74% and a Return on Assets (ROA) of 5.54%, showing reasonable returns on capital employed.